Patents-Review.com
ClassID:

20537 ⎘

A61K31/713 - page 7 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having three or more nucleosides or nucleotides Double-stranded nucleic acids or oligonucleotides

Recent Application in this class:
#1801
20190211333
2019-07-11

Targeting Ligands For Therapeutic Compounds

 #1802
20190211328
2019-07-11

Polycation-Functionalized Nanoporous Silicon Carrier for Systemic Delivery of Gene Silencing Agents

 #1803
20190211327
2019-07-11

RAAV-based compositions and methods

 #1804
20190209703
2019-07-11

Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, Bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer

 #1805
20190209698
2019-07-11

POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY

 #1806
20190209690
2019-07-11

Bioreducible Poly (Beta-Amino Ester)s For siRNA Delivery

 #1807
20190209669
2019-07-11

PEPTIDE VACCINES AND DURVALUMAB FOR TREATING BREAST CANCER

 #1808
20190209570
2019-07-11

Methods and Pharmaceutical Compositions for Treating Lymphoid Malignancy

 #1809
20190203210
2019-07-04

Increasing ATOH1 life to drive sensorineural hair cell differentiation

 #1810
20190203207
2019-07-04

Anabolic Enhancers for Ameliorating Neurodegeneration

 #1811
20190201489
2019-07-04

COMPOSITIONS AND METHODS FOR PREVENTING BONE LOSS AND/OR STIMULATING BONE HEALING

 #1812
20190194689
2019-06-27

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

 #1813
20190194688
2019-06-27

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

 #1814
20190194664
2019-06-27

Use of Rad18 inhibitors in the treatment of tumors

 #1815
20190194663
2019-06-27

MicroRNA-198 as a tumor suppressor in ovarian cancer

 #1816
20190194281
2019-06-27

Vesicles comprising lectins expressed on the surface and methods of use thereof to deliver an agent to autophagic and apoptotic cells

 #1817
20190192689
2019-06-27

Lipid nanoparticle compositions and methods for mRNA delivery

 #1818
20190192681
2019-06-27

Nucleic acid-polypeptide compositions and uses thereof

 #1819
20190192679
2019-06-27

Nanocarriers and intracellular delivery of same

 #1820
20190192676
2019-06-27

Immunostimulant

 #1821
20190192661
2019-06-27

Topical formulations based on ionic species for skin treatment

 #1822
20190192550
2019-06-27

Particles with RNA cleaving nucleobase polymers and uses for managing inflammatory disorders

 #1823
20190192432
2019-06-27

Multi-functional particles and methods of using the same

 #1824
20190184018
2019-06-20

Carbohydrate conjugates as delivery agents for oligonucleotides

 #1825
20190183918
2019-06-20

SYSTEMIC IN VIVO DELIVERY OF OLIGONUCLEOTIDES

 #1826
20190178896
2019-06-13

MARKER FOR THE CLASSIFICATION, DIAGNOSIS AND TREATMENT OF SCOLIOSIS

 #1827
20190177801
2019-06-13

Methods of detecting DDR2 mutations

 #1828
20190177728
2019-06-13

MiR-127 agents for use in the treatment of renal fibrosis

 #1829
20190177727
2019-06-13

Methods for diagnosing and treating metastatic cancer

 #1830
20190177724
2019-06-13

Exon skipping compositions for treating muscular dystrophy

 #1831
20190175761
2019-06-13

Lipid nanoparticle compositions and methods for mRNA delivery

 #1832
20190175671
2019-06-13

MICRORNA 22 REGULATORS COMPOSITIONS AND METHODS AND USES THEREOF

 #1833
20190175542
2019-06-13

METHODS OF TREATING AGE RELATED DISORDERS

 #1834
20190169615
2019-06-06

Modulation of BCL11A for treatment of hemoglobinopathies

 #1835
20190169612
2019-06-06

Methods of Manipulating the Fate of Cells

 #1836
20190167803
2019-06-06

TLR9 TARGETED CYTOTOXIC AGENTS

 #1837
20190167800
2019-06-06

Lipids and compositions for the delivery of therapeutics

 #1838
20190167737
2019-06-06

Use of IAP inhibitor and oncolytic virus in preparation of anti-tumor drug

 #1839
20190167713
2019-06-06

Medicament for the treatment of acute liver failure

 #1840
20190167712
2019-06-06

MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE- ASSOCIATED MEDICAL CONDITIONS

 #1841
20190167708
2019-06-06

Tumor suppressor TET1 and uses thereof

 #1842
20190167641
2019-06-06

Use of VCP inhibitor and oncolytic virus in the preparation of an anti-tumor drug

 #1843
20190160184
2019-05-30

Means and methods to treat dystonia

 #1844
20190160176
2019-05-30

Targeted nucleic acid conjugate compositions

 #1845
20190160169
2019-05-30

Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers

 #1846
20190160091
2019-05-30

Compositions and methods for treating Huntington's disease

 #1847
20190153447
2019-05-23

Method of fixing and expressing physiologically active substance

 #1848
20190153444
2019-05-23

Targeting MicroRNAs for Metabolic Disorders

 #1849
20190153442
2019-05-23

Methods for treatment of polycystic kidney disease

 #1850
20190153412
2019-05-23

Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disorders

 #1851
20190153016
2019-05-23

Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides

 #1852
20190151469
2019-05-23

RNA containing composition for treatment of tumor diseases

 #1853
20190151346
2019-05-23

COMBINATIONS THERAPIES FOR THE TREATMENT OF CANCER

 #1854
20190151345
2019-05-23

Administration of polynucleotide toll-like receptor 9 agonists for treating cancer

 #1855
20190151344
2019-05-23

Agent for inducing cell death, agent for suppressing cell proliferation, and pharmaceutical composition used for treatment of disease resulting from abnormal cell proliferation

 #1856
20190144866
2019-05-16

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

 #1857
20190144860
2019-05-16

RNAi induced huntingtin gene suppression

 #1858
20190144859
2019-05-16

Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA

 #1859
20190144857
2019-05-16

T cell differentiation and function regulation by decreasing let7 expression

 #1860
20190142968
2019-05-16

Compositions and methods for selective inhibition of grainyhead-like protein expression

 #1861
20190142966
2019-05-16

Functionalized Nanoparticles and Compositions for Cancer Treatment and Methods

 #1862
20190142857
2019-05-16

Methods for promoting entry of an agent into a cell

 #1863
20190142751
2019-05-16

Liposomes comprising polymer-conjugated lipids and related uses

 #1864
20190136243
2019-05-09

Method for preventing or treating obesity by using a composition including HOGA1-inhibiting substance and method of screening a preventive or therapeutic agent for obesity by using the composition

 #1865
20190136232
2019-05-09

Compositions and methods for manipulation of adipocyte energy consumption regulatory pathway

 #1866
20190135944
2019-05-09

Cell based anti-cancer compositions with reduced toxicity and methods of making the same

 #1867
20190134214
2019-05-09

GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof

 #1868
20190134141
2019-05-09

METHODS OF DOWNREGULATING TRANSLOCATED ONCOGENE EXPRESSION USING BROMODOMAIN INHIBITORS

 #1869
20190134077
2019-05-09

PROCESS FOR THE IDENTIFICATION OF COMPOUNDS FOR TREATING CANCER

 #1870
20190127804
2019-05-02

Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer

 #1871
20190127734
2019-05-02

MIR-29 MIMICS AND USES THEREOF

 #1872
20190127682
2019-05-02

Nucleic acid and other compositions and methods for the modulation of cell membranes

 #1873
20190127318
2019-05-02

Ionizable compounds and compositions and uses thereof

 #1874
20190125885
2019-05-02

Stabilization of biomolecules using sugar polymers

 #1875
20190125884
2019-05-02

COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES

 #1876
20190125830
2019-05-02

Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration

 #1877
20190125795
2019-05-02

Compositions and methods for immune cell modulation in adoptive immunotherapies

 #1878
20190119685
2019-04-25

Compositions and methods for inhibiting expression of TMPRSS6 gene

 #1879
20190119684
2019-04-25

Methods for improving cognitive function via modulation of quinone reductase 2

 #1880
20190119677
2019-04-25

MicroRNA-143 derivative

 #1881
20190119673
2019-04-25

METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES

 #1882
20190119320
2019-04-25

Inhibitors of metastasis

 #1883
20190117798
2019-04-25

Compositions and methods for delivery of agents

 #1884
20190117751
2019-04-25

TUMOR ANTIGEN PEPTIDE

 #1885
20190117685
2019-04-25

PROCESS FOR THE IDENTIFICATION OF COMPOUNDS FOR TREATING CANCER

 #1886
20190117659
2019-04-25

Methods for treating renal disease

 #1887
20190117642
2019-04-25

Targeting AMP deaminase 2 for ameliorating craving for sugar and other substances

 #1888
20190112665
2019-04-18

COMPOSITIONS AND METHODS FOR PROGNOSIS OF OVARIAN CANCER

 #1889
20190112610
2019-04-18

Endomucin inhibitor as an anti-angiogenic agent

 #1890
20190112606
2019-04-18

Complex containing oligonucleotide having immunopotentiating activity and use thereof

 #1891
20190112603
2019-04-18

Methods and compositions for managing vascular conditions using miR-483 mimics and HIF1alpha pathway inhibitors

 #1892
20190111120
2019-04-18

NOVEL CANCER ANTIGEN EEF2

 #1893
20190111070
2019-04-18

Metabolically stabilized double stranded mRNA

 #1894
20190106694
2019-04-11

GNAQ targeted dsRNA compositions and methods for inhibiting expression

 #1895
20190106379
2019-04-11

NOVEL CYCLIC CATIONIC LIPIDS AND METHODS OF USE

 #1896
20190105341
2019-04-11

Compositions and Methods for Treating Alzheimer's Disease and Other Tauopathies

 #1897
20190100757
2019-04-04

Conserved HBV and HCV sequences useful for gene silencing

 #1898
20190099493
2019-04-04

Targeting Lipids

 #1899
20190099456
2019-04-04

COMPOSITION FOR PROMOTING INTERFERON LAMBDA PRODUCTION AND PRODUCTION METHOD THEREFOR

 #1900
20190099453
2019-04-04

Medicament for liver regeneration and for treatment of liver failure

 #1901
20190093167
2019-03-28

Methods of using miRNAs from bodily fluids for detection and differentiation of neurodegenerative diseases

 #1902
20190091344
2019-03-28

Amphipathic peptide

 #1903
20190091265
2019-03-28

MEDICAMENT FOR LIVER REGENERATION AND FOR TREATMENT OF LIVER FAILURE

 #1904
20190091254
2019-03-28

Treatment of cancer by systemic administration of Dbait molecules

 #1905
20190091253
2019-03-28

Therapies for cardiomyopathy

 #1906
20190091220
2019-03-28

TARGETING PARP1 FOR TREATMENT OF TSC AND CANCERS

 #1907
20190091164
2019-03-28

Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same

 #1908
20190091160
2019-03-28

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

 #1909
20190085093
2019-03-21

Composition for regulating cell division comprising FCHO1 modulator, and method for regulating cell division using same

 #1910
20190084965
2019-03-21

Amine cationic lipids and uses thereof

 #1911
20190083650
2019-03-21

TKI permeability enhancers

 #1912
20190083611
2019-03-21

Composition comprising PIC for treatment of cancer

 #1913
20190083522
2019-03-21

BIOSYNTHETIC MODULES

 #1914
20190083487
2019-03-21

Efficacy of anti-HLA-DR antibody drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers

 #1915
20190083451
2019-03-21

Synergistic effect of anti-trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors

 #1916
20190083312
2019-03-21

DEVICES AND METHODS FOR TREATMENT OF OCULAR DISORDERS THROUGH DELIVERY OF THERAPEUTIC NUCLEIC ACIDS

 #1917
20190078147
2019-03-14

DETECTION OF RECOMBINASE POLYMERASE AMPLIFICATION USING DUAL-HAPTEN PROBE

 #1918
20190078095
2019-03-14

Antisense antibacterial compounds and methods

 #1919
20190078092
2019-03-14

Preventing tumor development and metastasis

 #1920
20190077825
2019-03-14

Methods of modulating KEAP1

 #1921
20190076475
2019-03-14

Materials and methods for increasing immune responses

 #1922
20190076464
2019-03-14

CYTIDINE DEAMINASE INHIBITORS FOR THE TREATMENT OF PANCREATIC CANCER

 #1923
20190076459
2019-03-14

Enhancing plasmin activity to prevent soft tissue calcification

 #1924
20190076457
2019-03-14

Nanoparticle to target cancer

 #1925
20190071679
2019-03-07

ANTI-TUMOR THERAPY

 #1926
20190071678
2019-03-07

Modulation of DYRK1B expression

 #1927
20190071676
2019-03-07

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

 #1928
20190071675
2019-03-07

INHIBITORS OF DEK PROTEIN AND RELATED METHODS

 #1929
20190071670
2019-03-07

Methods Of Treatment For Alpha-1 Antitrypsin Deficiency

 #1930
20190070308
2019-03-07

Antibody-drug conjugates and uses thereof

 #1931
20190064149
2019-02-28

Cancer examination method and examination kit

 #1932
20190062751
2019-02-28

Tumor cell malignant transformation suppressor and anti-tumor agent

 #1933
20190062748
2019-02-28

Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo

 #1934
20190062745
2019-02-28

MicroRNA composition for the treatment of neuroblastoma

 #1935
20190062437
2019-02-28

Nucleic acid-polypeptide compositions and uses thereof

 #1936
20190062436
2019-02-28

Nucleic acid-polypeptide compositions and uses thereof

 #1937
20190060488
2019-02-28

Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety

 #1938
20190060347
2019-02-28

Microbubble complexes and methods of use

 #1939
20190055565
2019-02-21

Prevention, diagnosis and treatment of cancer overexpressing GPR160

 #1940
20190055563
2019-02-21

POLYMERASE Q AS A TARGET IN HR-DEFICIENT CANCERS

 #1941
20190055562
2019-02-21

Methods and compositions using RNA interference for inhibition of KRAS

 #1942
20190055558
2019-02-21

Nucleic acid conjugate

 #1943
20190055557
2019-02-21

Compositions and Methods For Treating Cachexia

 #1944
20190055556
2019-02-21

Targeting pleiotrophin signaling to limit high-grade glioma invasion

 #1945
20190055554
2019-02-21

COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION

 #1946
20190054189
2019-02-21

RNA containing composition for treatment of tumor diseases

 #1947
20190054148
2019-02-21

Cell membrane-permeating peptide

 #1948
20190054130
2019-02-21

Treatment methods using adenovirus

 #1949
20190054111
2019-02-21

TALEN-based gene correction

 #1950
20190054110
2019-02-21

MODULATORS OF CCR9 FOR TREATING TUMOR RESISTANCE TO IMMUNE RESPONSES

 #1951
20190048352
2019-02-14

Compositions and methods for inhibiting expression of CD274/PD-L1 gene

 #1952
20190048346
2019-02-14

COMPOSITIONS AND METHODS FOR DELIVERING MICRORNA

 #1953
20190048344
2019-02-14

CHEMICAL MODIFICATIONS OF MONOMERS AND OLIGONUCLEOTIDES WITH CYCLOADDITION

 #1954
20190048342
2019-02-14

CROSS-REGULATION OF TYPE I INTERFERON SIGNALING PATHWAYS

 #1955
20190048341
2019-02-14

Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA

 #1956
20190048139
2019-02-14

Biodegradable cationic polymers and uses thereof

 #1957
20190046551
2019-02-14

Pharmaceutical composition for treating and/or preventing cancer

 #1958
20190040448
2019-02-07

METHODS OF DIAGNOSING AND TREATING B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

 #1959
20190040416
2019-02-07

Cas discrimination using tuned guide RNA

 #1960
20190040388
2019-02-07

HIPPO AND DYSTROPHIN COMPLEX SIGNALING IN CARDIOMYOCYTE RENEWAL

 #1961
20190040122
2019-02-07

BIOLOGICAL MATERIALS AND USES THEREOF

 #1962
20190038758
2019-02-07

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

 #1963
20190038658
2019-02-07

High density lipoprotein binding protein (Hdlbp/Vigilin) iRNA compositions and methods of use thereof

 #1964
20190038657
2019-02-07

Compositions and methods for treating fibrotic disease

 #1965
20190038557
2019-02-07

MEANS FOR LUNG SPECIFIC DELIVERY

 #1966
20190038538
2019-02-07

RNA complexes that inhibit melanin production

 #1967
20190032079
2019-01-31

SYSTEMIC SYNTHESIS AND REGULATION OF L-DOPA

 #1968
20190032061
2019-01-31

RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related Conditions

 #1969
20190032051
2019-01-31

NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY

 #1970
20190031756
2019-01-31

Methods and pharmaceutical compositions for enhancing CD8+ T cell-dependent immune responses in subjects suffering from cancer

 #1971
20190030175
2019-01-31

Antibody-SN-38 immunoconjugates with a CL2A linker

 #1972
20190030161
2019-01-31

BREAST CANCER THERAPEUTICS

 #1973
20190030060
2019-01-31

Method for monitoring cancer and for regulation of semaphorin 4D to improve cancer immunotherapy regimens

 #1974
20190024089
2019-01-24

Interfering RNA molecules

 #1975
20190024084
2019-01-24

Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity

 #1976
20190024073
2019-01-24

EDITING MITOCHONDRIAL DNA

 #1977
20190023781
2019-01-24

THERAPEUTIC DRUG FOR MALIGNANT TUMORS

 #1978
20190023780
2019-01-24

ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ORAL MUCOSITIS

 #1979
20190022226
2019-01-24

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

 #1980
20190022126
2019-01-24

Antiviral drugs

 #1981
20190022124
2019-01-24

Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

 #1982
20190022123
2019-01-24

RNAi therapy for hepatitis B virus infection

 #1983
20190017089
2019-01-17

MYO1A for predicting conversion of acute pain into chronic pain and use of MYO1A for therapy of pain

 #1984
20190017051
2019-01-17

Oligonucleotide compositions with enhanced efficiency

 #1985
20190015442
2019-01-17

Dual molecular delivery of oligonucleotides and peptide containing conjugates

 #1986
20190015441
2019-01-17

Compositions and methods for treating malignant, autoimmune and inflammatory diseases

 #1987
20190015422
2019-01-17

Methods for treating brain metastases using combinations of anti-P13K and anti-mTOR agents

 #1988
20190015405
2019-01-17

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

 #1989
20190010555
2019-01-10

SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER

 #1990
20190010502
2019-01-10

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE

 #1991
20190010500
2019-01-10

PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS

 #1992
20190010492
2019-01-10

Monocarboxylate transporter 4 (MCT) antisense oligonucleotide (ASO) inhibitors for use as therapeutics in the treatment of cancer

 #1993
20190008882
2019-01-10

Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits

 #1994
20190004053
2019-01-03

Methods of detecting and reducing cancer cell central nervous system colonization

 #1995
20190002884
2019-01-03

Methods of treating cancer by inhibition of DNA repair proteins using antisense based therapies

 #1996
20190002880
2019-01-03

DOUBLE-STRANDED OLIGONUCLEOTIDES

 #1997
20190002569
2019-01-03

Methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway

 #1998
20190002499
2019-01-03

Peptides and nanoparticles for intracellular delivery of molecules

 #1999
20190002393
2019-01-03

Lipids and lipid compositions for the delivery of active agents

 #2000
20190000990
2019-01-03

Carrier nanoparticles and related compositions, methods and systems

 #2001
20190000987
2019-01-03

Nucleic acid-polypeptide compositions and uses thereof

 #2002
20190000986
2019-01-03

Nucleic acid-polypeptide compositions and methods of inducing exon skipping

 #2003
20190000838
2019-01-03

Synthetic lethality and the treatment of cancer

 #2004
20180371459
2018-12-27

Compositions and methods for controlling arthropod parasite and pest infestations

 #2005
20180371418
2018-12-27

Formulation comprising extracellular vesicles, method for producing the same, and uses thereof

 #2006
20180371102
2018-12-27

Nucleic acid-polypeptide compositions and uses thereof

 #2007
20180369400
2018-12-27

Nucleic acid-polypeptide compositions and methods of inducing exon skipping

 #2008
20180369396
2018-12-27

Targeted sensitization of non-del(5q) malignant cells

 #2009
20180369386
2018-12-27

Lipids and lipid compositions for the delivery of active agents

 #2010
20180369384
2018-12-27

COMPOSITIONS FOR NUCLEIC ACID DELIVERY

 #2011
20180369374
2018-12-27

MRNA combination therapy for the treatment of cancer

 #2012
20180369327
2018-12-27

METHOD FOR TREATING OR PREVENTING OSTEOARTHRITIS

 #2013
20180369275
2018-12-27

Antisense oligomers for treatment of autosomal dominant mental retardation-5 and Dravet Syndrome

 #2014
20180369271
2018-12-27

METHODS OF DELIVERING OLIGONUCLEOTIDES TO IMMUNE CELLS

 #2015
20180369140
2018-12-27

NANOVECTORS FOR PENETRATING BRAIN TUMOR TISSUES TO CONDUCT GENE THERAPY

 #2016
20180362985
2018-12-20

UNA oligomers having reduced off-target effects in gene silencing

 #2017
20180362984
2018-12-20

Methods and compositions for managing vascular conditions

 #2018
20180362983
2018-12-20

Methods and compositions for reprogramming cells

 #2019
20180362981
2018-12-20

Pharmaceutical composition for treating and/or preventing cancer

 #2020
20180362977
2018-12-20

RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

 #2021
20180362658
2018-12-20

ESOPHAGEAL CANCER MARKER AND USE THEREOF

 #2022
20180362625
2018-12-20

REGULATION OF CYTOKINE PRODUCTION

 #2023
20180360866
2018-12-20

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

 #2024
20180360819
2018-12-20

ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT

 #2025
20180360797
2018-12-20

Treatment of tinnitus through modulation of chloride co-transporter NKCC1 in the auditory system

 #2026
20180355362
2018-12-13

Organic compositions to treat beta-ENaC-related diseases

 #2027
20180355357
2018-12-13

Peptide, Complex of Peptide and siRNA, and Methods of Use Thereof

 #2028
20180353610
2018-12-13

SYSTEMS AND METHODS OF DELIVERY OF BIOACTIVE AGENTS USING BACTERIAL TOXIN-DERIVED TRANSPORT SEQUENCES

 #2029
20180353533
2018-12-13

POLYINOSINIC-POLYCYTIDYLIC ACID (POLY (I:C)) PEA STARCH FORMULATION FOR THE PREVENTION AND/OR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS

 #2030
20180353532
2018-12-13

Double-stranded nucleic acid molecule, DNA, vector, cancer cell growth inhibitor, cancer cell migration inhibitor, and drug

 #2031
20180353434
2018-12-13

Nucleic acid-containing lipid nanoparticles

 #2032
20180348220
2018-12-06

DNA aptamer binding to cancer cell

 #2033
20180346933
2018-12-06

Methods and compositions for reprogramming cells

 #2034
20180346914
2018-12-06

MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER

 #2035
20180346910
2018-12-06

Serpina1 iRNA compositions and methods of use thereof

 #2036
20180346906
2018-12-06

Methods of reducing expression of X-inactivation escapee genes and autosomal genes

 #2037
20180344874
2018-12-06

Cysteine Peptide-Containing Health Drink

 #2038
20180344760
2018-12-06

Use of antisense oligonucleotides for producing truncated Ig by exon skipping for the treatment of diseases involving B cells

 #2039
20180339022
2018-11-29

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS

 #2040
20180338963
2018-11-29

Donor organ pre-treatment formulation

 #2041
20180334674
2018-11-22

Antitumor drug delivery formulation

 #2042
20180327753
2018-11-15

Means and methods for reducing tumorigenicity of cancer stem cells

 #2043
20180327751
2018-11-15

siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)

 #2044
20180327495
2018-11-15

Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic cancers

 #2045
20180326070
2018-11-15

CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES

 #2046
20180325992
2018-11-15

MODULATION OF AXON DEGENERATION

 #2047
20180325940
2018-11-15

Composition for ameliorating loss of hair and graying of hair, and use thereof

 #2048
20180325939
2018-11-15

Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections

 #2049
20180325938
2018-11-15

METHOD OF EVALUATING OR SELECTING ANDROGEN RECEPTOR ACTIVITY REGULATOR SELECTIVE TO SEBACEOUS GLANDS OR HAIR FOLLICLES

 #2050
20180325918
2018-11-15

Immunoregulatory agent

 #2051
20180325890
2018-11-15

Methods and pharmaceutical compostions for treating rhabdomyolysis

 #2052
20180325820
2018-11-15

BIOCOMPATIBLE WATER-SOLUBLE POLYMERS INCLUDING SULFOXIDE FUNCTIONALITY

 #2053
20180320187
2018-11-08

Toxic RNAi active seed sequences for killing cancer cells

 #2054
20180320182
2018-11-08

Methods and Compositions for Selecting siRNA of Improved Functionality

 #2055
20180320132
2018-11-08

Agents and methods for treating and preventing seborrheic keratosis

 #2056
20180318448
2018-11-08

Method for determining presence or absence of suffering from malignant lymphoma or leukemia, and agent for treatment and/or prevention of leukemia

 #2057
20180318430
2018-11-08

Complex comprising RNAi molecule and N-acetylated chitosan

 #2058
20180318423
2018-11-08

Nanostructured gels capable of controlled release of encapsulated agents

 #2059
20180318405
2018-11-08

Targeting CAPN9/CAPNS2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies

 #2060
20180318389
2018-11-08

NMDAR antagonists for the treatment of diseases associated with angiogenesis

 #2061
20180318331
2018-11-08

Method for treating schizophrenia

 #2062
20180318298
2018-11-08

Method of treating obesity

 #2063
20180318260
2018-11-08

COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS

 #2064
20180312929
2018-11-01

Methods and compositions related to T-cell activity

 #2065
20180312867
2018-11-01

Identification and use of target genes for control of plant parasitic nematodes

 #2066
20180312840
2018-11-01

COMPOUNDS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION FOR IMPROVING A DIABETIC PROFILE

 #2067
20180311506
2018-11-01

System comprising a nucleotide sequence encoding a volvox carteri light-activated ion channel protein (VCHR1)

 #2068
20180306796
2018-10-25

Methods and compositions relating to proteasome inhibitor resistance

 #2069
20180305696
2018-10-25

METHODS AND COMPOSITIONS FOR PREVENTING ISCHEMIA REPERFUSION INJURY IN ORGANS

 #2070
20180305693
2018-10-25

Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene

 #2071
20180305690
2018-10-25

Targeting MicroRNAs for the Treatment of Fibrosis

 #2072
20180303864
2018-10-25

POLYNUCLEOTIDES HAVING BIOREVERSIBLE GROUPS

 #2073
20180303863
2018-10-25

Pharmaceutical Composition for Treating STK11-Mutation Cancer Using Cardiac Glycosides

 #2074
20180303775
2018-10-25

Hair-growth promoting composition and usage thereof

 #2075
20180298383
2018-10-18

Peptide oligonucleotide conjugates

 #2076
20180298380
2018-10-18

Modified AAV constructs and uses thereof

 #2077
20180298101
2018-10-18

Inhibition of cytokine-induced SH2 protein in NK cells

 #2078
20180297938
2018-10-18

Compounds for targeting drug delivery and enhancing siRNA activity

 #2079
20180296684
2018-10-18

TARGETED THERAPEUTIC NUCLEOSIDES AND THEIR USE

 #2080
20180296638
2018-10-18

Compositions for treating heart disease by inhibiting the action of mAKAP-β

 #2081
20180291432
2018-10-11

Rapid identification of microorganisms

 #2082
20180291381
2018-10-11

Interfering RNA molecules

 #2083
20180291377
2018-10-11

Blood Brain Barrier Opening Agents and Uses Thereof

 #2084
20180290965
2018-10-11

Lipids and lipid compositions for the delivery of active agents

 #2085
20180289835
2018-10-11

Micelle composition for nucleic acid delivery using temperature-sensitive polymer and method for producing same

 #2086
20180282733
2018-10-04

Therapeutic agent for sarcopenia and metabolic diseases

 #2087
20180282730
2018-10-04

Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics

 #2088
20180282728
2018-10-04

ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES

 #2089
20180282725
2018-10-04

Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene

 #2090
20180280526
2018-10-04

Plasma cell cytokine vehicle containing fusion proteins for targeted introduction of siRNA into cells and tissues

 #2091
20180280490
2018-10-04

METHODS AND COMPOSITIONS FOR PREVENTING A CONDITION

 #2092
20180280407
2018-10-04

METHODS TO TARGET TRANSCRIPTIONAL CONTROL AT SUPER-ENHANCER REGIONS

 #2093
20180280357
2018-10-04

Methods for treating Angelman syndrome and related disorders

 #2094
20180280324
2018-10-04

Histone deacetylase inhibitors for the use in the treatment of drug resistant melanoma

 #2095
20180273955
2018-09-27

Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof

 #2096
20180273953
2018-09-27

Compositions and methods for modulating apolipoprotein (a) expression

 #2097
20180273952
2018-09-27

Compositions and methods for modulating apolipoprotein C-III expression

 #2098
20180273950
2018-09-27

Methods and compositions for the production of siRNAs

 #2099
20180273947
2018-09-27

Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof

 #2100
20180273638
2018-09-27

LIN28- MEDIATED CONTROL OF LET-7 BIOGENESIS